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Abstract 14 
Farrowing is a critical time for sows and piglets. Poor post-farrowing sow recovery, 15 
and piglet mortality represent a welfare concern, as well as an economic loss to the pig industry. 16 
Providing a non-steroidal anti-inflammatory drug (NSAID) to the sow post-farrowing may 17 
improve sow welfare and productivity and thereby improve health status and welfare of the 18 
piglets, which would be of economic benefit to pig producers. This study investigated the 19 
production effects of providing the NSAID ketoprofen post-farrowing, to 24 primiparous (gilts) 20 
and 32 multiparous (sows) breeding pigs, in a randomised, blinded, placebo-controlled trial. 21 
Gilts and sows were allocated to receive ketoprofen (treated) or the equivalent volume of saline 22 
(control) by intramuscular injection 1.5 hours after the last piglet birth. Data collected included 23 
sow feed intake, immune transfer (colostrum and piglet serum immunoglobulin-G (IgG)), 24 
nursing behaviour and piglet weight, and mortality. An additional factor in this study was that 25 
13 individuals required additional treatment in the days after farrowing for post-farrowing 26 
illness. Therefore, data were analysed using mixed models, including treatment (treated or 27 
control), parity group (gilt or sow), and additional treatment (yes or no) as fixed factors. 28 
Stepwise binomial logistic regression was used to analyse the association between the 29 
experimental factors (treatment, additional treatment, gilt or sow), along with other gilt/sow, 30 
litter, and piglet-based measures, with piglet death before weaning. Few treatment effects were 31 
seen, with parameters being more affected by whether gilts and sows were treated for illness, 32 
or between gilts and sows. The only variable to differ by treatment was suckle grunt duration, 33 
which was greater for control compared with treated dams (P = 0.05). Feed consumption was 34 
greater for sows compared with gilts on days 6 and 7 post-farrowing, and serum IgG was 35 
greater in piglets from sows than gilts (P < 0.05). Feed consumption was reduced in dams 36 
needing additional treatment, from days 2-7 post-farrowing, and those developing illness 37 
consumed less feed overall (P = 0.004). The best regression model for predicting the odds of a 38 
  
piglet dying before weaning included number born alive (P = 0.03), requiring additional 39 
treatment (P = 0.006), being male (P = 0.0005), and pre-farrowing gilt/sow back-fat (P < 40 
0.0001), which increased the log-odds of death, whereas, piglet body weight decreased the log-41 
odds of death (P < 0.0001). This study did not demonstrate clear benefits to ketoprofen, 42 
however, high individual variation in piglet mortality, indicates potential for targeted NSAID 43 
use.  44 
 45 
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Introduction 47 
 Farrowing is a critical time in pig production. A common feature of modern pig 48 
production is increased litter size, and as the sow must produce enough milk to feed the litter, 49 
feed volume and composition must adjust to cope with the increased demand (Theil, 2015).  50 
Further, each piglet must have access to a functioning teat as soon as possible after birth to 51 
consume colostrum, followed by milk in order to survive (Baxter et al., 2013). Therefore, the 52 
sow must recover quickly following farrowing, including feeding and drinking. However, at 53 
that time the immunocompetence of the sow is impaired and as parturition is physically 54 
demanding, the vulnerability to illness in early lactation is increased (Friendship and 55 
O’Sullivan, 2015).  56 
Post-partum dysgalactia syndrome (PPDS) describes any condition that affects milk 57 
production in the sow, including infections of the uterine tract (metritis) and udder (mastitis), 58 
but milk production can also decline with no obvious signs of infection (Klopfenstein et al., 59 
2006). A number of non-infectious causes of PPDS have been discussed (Klopfenstein et al., 60 
2006) and pain experienced by the sow could contribute to a decreased interest in the piglets 61 
  
and a reduction in milk let down (Peltoniemi and Oliviero, 2015). This has resulted in recent 62 
research administering non-steroidal anti-inflammatory drugs (NSAIDs) post-farrowing and 63 
measuring the benefits to health, welfare and productivity (Homedes et al., 2014; Mainau et 64 
al., 2016, 2012; Sabaté et al., 2012; Tenbergen et al., 2014; Viitasaari et al., 2014, 2013).  65 
A previous study, involving 15 commercial farms, investigated the production benefits 66 
of providing the NSAID ketoprofen post-farrowing to all sows, and demonstrated a reduction 67 
in piglet mortality and a greater number of piglets weaned (Homedes et al., 2014). Another 68 
study found no piglet performance benefits of administering ketoprofen, but did identify other 69 
sow health and welfare benefits including a reduced loss in back-fat, body condition and 70 
constipation, less severe shoulder sores, and a delay in feed refusal (Viitasaari et al., 2013). 71 
Two studies in which meloxicam was administered after farrowing found no mortality 72 
differences but did show an increased average daily weight gain of low birth weight piglets 73 
(Mainau et al., 2012) and a tendency for increased piglet weight gain of litters of 11 to 13 74 
piglets (Tenbergen et al., 2014). Another study using oral meloxicam, demonstrated 75 
improvements in piglet weaning weight, average daily gain, and plasma IgG concentrations 76 
measured on day 1 and 2 post-farrowing (Mainau et al., 2016). The administration of NSAIDs 77 
in addition to antibiotics has also been shown to aid in treatment of infectious causes of PPDS 78 
(e.g. Hirsch et al., 2003; Tummaruk and Sang-Gassanee, 2013) and on a farm with a high 79 
incidence of PPDS, piglet mortality was reduced and the number of piglets weaned increased 80 
in sows given ketoprofen and antibiotics (Sabaté et al., 2012).   81 
Ketoprofen is an NSAID with anti-inflammatory, analgesic, and antipyretic properties, 82 
which was shown to reach maximum levels approximately one hour after intramuscular (IM) 83 
injection in pigs (Raekallio et al., 2008), and reduced nociceptive thresholds in piglets with 84 
kaolin-induced inflammation up to 24 hours after IM injection (Fosse et al., 2011). This study 85 
investigated the use of ketoprofen after farrowing for primiparous (hereafter referred to as gilts) 86 
  
and multiparous (referred to as sows) breeding pigs. The aim was to evaluate the benefits of 87 
post-farrowing ketoprofen in terms of: i) gilt/sow feed intake; ii) immune transfer using IgG 88 
from colostrum and piglet serum; iii) piglet performance including growth and mortality; and 89 
iv) nursing behaviour. Based on previous studies, our hypothesis was that prompt post-90 
farrowing treatment with ketoprofen improves sow recovery, including feed intake, and piglet 91 
performance through immune transfer and nursing behaviour. 92 
Materials and Methods 93 
 This experiment was carried out under UK Home Office Licence, in compliance with 94 
EU Directive 2010/63/EU and following approval from the SRUC Animal Welfare and Ethical 95 
Review Body (AWERB). 96 
Animal housing and husbandry 97 
 Thirty-two Large White × Landrace multiparous (mean parity 4.63 ± 0.43) and 24 98 
primiparous sows were used in this study. The study was carried out at the SRUC pig research 99 
farm (Midlothian, UK), with gilts and sows farrowing in nine batches between February and 100 
October 2014. No more than five days before the expected farrowing date, gilts and sows were 101 
moved into individual farrowing crates (1.8 × 0.5 m), with solid concrete flooring (1.8 × 1.5 102 
m), a small slatted area at the back (0.5 × 0.5 m) and a water and feed trough at the front. Piglets 103 
had access to a heated creep area (1.5 × 0.65 m) in front of the water and feed trough. Gilts and 104 
sows were fed a standard pelleted lactation diet twice daily at 0745 and 1530 and had 105 
continuous access to fresh water. Gilt and sow crates were cleaned daily at the morning feed, 106 
and they were provided with fresh, long-stemmed straw. Additional straw was added and 107 
manure removed at the afternoon feed in the days preceding farrowing. Lights were switched 108 
on immediately before the morning feed, turned off at 1630 and an additional night-light was 109 
provided in the centre of each room of crates.  110 
  
During the experiment and only after the six hour post-injection data collection, cross-111 
fostering was conducted where necessary to even up litter sizes to maximise piglet survival as 112 
per normal farm practice. Cross fostering was conducted regardless of experimental treatments. 113 
When litter sizes were uneven, the largest piglet(s) were removed and placed on a gilt or sow 114 
with a smaller litter. Beyond the time of cross-fostering, data for individual foster piglets was 115 
then recorded against the foster sow. Piglets received an intramuscular injection of iron on day 116 
3 post-farrowing, and on the fourth week after farrowing (mean age 26.39 ± 0.20), weaning 117 
took place. At weaning, piglets were ear tagged and vaccinated (CircoFLEX) as per farm 118 
practice. 119 
Blinding and treatments 120 
This study was a randomised, blinded, placebo controlled trial, with gilts and sows 121 
allocated to receive a single intra-muscular (IM) injection of ketoprofen (Ketofen; Merial 122 
Animal Health Limited, Harlow, Essex, UK) or the equivalent volume of saline, 90 minutes 123 
following the birth of the last piglet.  Gilts and sows in each batch were randomly allocated to 124 
receive either ketoprofen (treated; 3 mg per kg bodyweight or 1 ml per 33 kg pre-farrowing 125 
bodyweight rounded down to the nearest 0.5 ml) or the equivalent volume of saline as a placebo 126 
control (control). The 56 individuals were balanced as much as possible across batches and for 127 
parity over the two treatment groups, however, an error in the treatment allocation, resulted in 128 
unbalanced groups for gilts (gilts: treated, n = 11, control, n = 13; sows: parity 2 to 4; treated, 129 
n = 9, control, n = 8; parity 5 to 7; treated, n = 5, control, n = 6; parity 8+; treated, n = 2, control, 130 
n = 2). One experimenter allocated individuals to the two treatment groups and a second added 131 
the ketoprofen or saline to individual brown medicine bottles, sealed with rubber stoppers 132 
(Adelphi Healthcare Packaging, Haywards Heath, West Sussex, UK), which were labelled only 133 
with the individual gilt or sow ear tag for identification. Ketofen contains the active ingredient 134 
  
ketoprofen at 100 mg/ml contained in a solution of l arginine, benzyl alcohol (10 mg/ml), citric 135 
acid monohydrate and water. It is a clear colourless solution, with low viscosity, making it 136 
indistinguishable from the saline placebo to the third experimenter administering the injection, 137 
who was unaware of the treatment.  138 
Individuals were closely monitored for signs of farrowing, by observation at twice daily 139 
feeding and through remote monitoring using a CCTV digital surveillance system around the 140 
clock. Once the piglet expulsion phase began, the time of each piglet birth was recorded; and 141 
90 minutes after the last piglet birth and the gilt or sow appeared to have finished farrowing, 142 
ketoprofen or saline was administered by intra-muscular injection. Ketoprofen or saline were 143 
injected into the neck muscle, just behind the ear using an 18 gauge, 1.5 inch needle attached 144 
to a PVC extension tube and using a 10 or 20 ml syringe (Henry Schein Animal Health, 145 
Dumfries, Dumfries and Galloway, UK). Following treatment administration, individuals were 146 
left undisturbed. 147 
Piglet measurements 148 
 Six hours after the treatment administration, the litters were processed and three piglets 149 
per litter were blood sampled. All piglets were collected and shut into the heated creep area 150 
during processing. Each piglet was weighed, crown-rump length measured (from the tail base 151 
to the top of the crown, in between the ears) and were labelled numerically on the back with a 152 
permanent marker. Three piglets per litter were selected to be blood sampled for 153 
immunoglobulin-G (IgG), based on weight: one less than 1.3 kg, one between 1.31 and 1.63 154 
kg and one greater than 1.64 kg, balanced across litters for sex. If piglets at all weight ranges 155 
were not available, alternatives were selected as close as possible, and very weak piglets were 156 
avoided.  157 
  
Selected piglets then had a topical local anaesthetic cream (EMLA) applied to their 158 
right ear. Each piglet was then held, while cotton wool soaked in hot water was applied to the 159 
right ear to promote vasodilation. A general purpose surgical steel lancet (HawksleyVet, 160 
Lancing, Sussex, UK) was used to make a small incision in the most prominent ear vein. Blood 161 
was allowed to pool briefly and collected into at least five 50 μl plain capillary tubes 162 
(HawksleyVet, Lancing, Sussex, UK). Blood was left to coagulate in the tubes for one hour at 163 
room temperature, before being sealed at one end using Cristaseal wax plates (HawksleyVet, 164 
Lancing, Sussex, UK), and then placed into a micro haemocrit centrifuge (HawksleyVet, 165 
Lancing, Sussex, UK)  for 1.5 minutes at 13,000 g. The end of the tube containing the 166 
condensed cells was cut off and the serum was pushed out of the remaining section of tube 167 
using a clean needle and syringe into a clean, pre-labelled 1.5 ml tube. Samples were then 168 
stored at -70 oC to be assayed at a later date.  169 
On day three post-farrowing, piglets were weighed when they were given a routine iron 170 
injection. At weaning, piglets were weighed and their crown-rump distance measured. All 171 
piglet deaths from birth to weaning were recorded and the cause of death identified by visual 172 
examination, and from video recording, including: still birth, crushing by the sow, low 173 
viability, starvation, savaged, ‘greasy pig’ (exudative epidermatis) and ‘other’ (unidentified 174 
causes). During the experiment, several litters were affected by exudative epidermatis, a 175 
bacterial skin infection, which was unrelated to the study, and was treated with long-acting 176 
antibiotics (amoxicillin). 177 
Gilt and sow measurements 178 
On moving in before farrowing and out at weaning, all gilts and sows were weighed, 179 
body condition scored (1 = very thin, 2 = thin, 3 = not too thin, not too fat, 4 = fat, 5 = very fat) 180 
  
and had their back-fat depth measured at the P2 position (Piglog 105; Carometec Food 181 
Technology, Smørum, Denmark).  182 
 At six hours after the treatment during piglet processing, a colostrum sample was 183 
collected from the dams. This was done by gently rubbing the udder, to ensure the dam was 184 
calm, then expressing colostrum from as many different teats as possible into a clean 30 ml 185 
plastic tube. Approximately 5 ml of colostrum was collected in the tube before pipetting into 186 
three 1.5 ml pre-labelled tubes, which were stored at -20oC to be assayed for IgG at a later date.  187 
 Gilt and sow feed intake was recorded on the day of farrowing, until seven days post-188 
farrowing. Individuals were fed a standard pelleted lactation diet consisting of 16.4% crude 189 
protein, 6.8 % crude oils and fats, 4.0% crude fibre, 5.8% crude ash, 13.8% moisture, 0.8% 190 
calcium, 0.94% lysine, 0.25% methionine, 0.51% phosphorus and 0.22% sodium. Gilts and 191 
sows were fed, based on a feed chart, which was adjusted slightly according to the size, body 192 
condition and appetite of the individual (e.g. gilts were fed slightly less than sows and a reduced 193 
body condition score was given slightly more feed). Feed intake was restricted, and increased 194 
gradually from day 0 to day 7. The amount fed was marked on the feed chart (in kg) and the 195 
amount left over from the previous feed was removed, weighed and recorded at the next feeding 196 
time. 197 
Behaviour 198 
Closed-circuit television (CCTV) cameras (LL20, infra-red cameras, FR concepts, 199 
Ireland) were mounted above each farrowing crate and were connected to a computer to record 200 
behaviour using GeoVision Digital Surveillance System software (ezCCTV ltd, Herts, UK). 201 
This surveillance system was also set up to enable remote monitoring of individuals. Digital 202 
video footage was collected and stored to be observed later using The Observer XT 11.0 203 
(Noldus Information Technology, Wageningen, The Netherlands). Three hour observations 204 
  
were made for suckling behaviour between 15 and 18 hours after the last piglet was born, to 205 
coincide with a regular pattern of milk let down and udder massage by the piglets, (Castren et 206 
al., 1989) which enabled obvious nursing bouts to be recognised on video. The frequencies and 207 
duration of suckle grunting (rapid flank movements indicating suckle grunting), whether more 208 
than 50% of piglets were active at the udder (performing udder massage/rapid suckling 209 
movements), as well as gilt and sow posture (stand, sit, kneel, lie lateral, lie ventral) and 210 
drinking behaviour (snout in the drinking trough with head movements indicating drinking 211 
behaviour) were recorded. 212 
Analysis of Immunoglobulin G (IgG) concentrations  213 
Sow colostrum and piglet serum samples were assayed for IgG using an enzyme linked 214 
immunosorbent assay (ELISA) kit (Bethyl Laboratories, Inc., Montgomery, Texas, USA). 215 
Colostrum and serum samples were removed from the freezer and allowed to thaw gradually 216 
at 4 oC overnight before the assay. On the day of the assay, samples were removed from the 217 
fridge, placed at room temperature for 30 minutes before further preparation.  218 
Colostrum samples were centrifuged twice at 16,249 g for 2 minutes, removing the fat 219 
layer after each spin. Serum samples were centrifuged for one minute at 865 g. Assays were 220 
then conducted according to the manufacturer’s instructions, with samples tested in duplicate. 221 
A test assay was run, indicating that a 1:500,000 dilution was best for both sample types. This 222 
dilution was created using serial dilution in, un-coated V-bottomed 96-well plates. 223 
Quality control (QCs) samples were created using pooled colostrum samples to run 224 
across and between plates to measure drift within and between plates. To avoid drift in the time 225 
taken to add the samples to the coated plate, 130 μl of standards, blanks, samples and QCs were 226 
added to an uncoated 96-well plate according to the plate layout, before using a multi-channel 227 
pipette to transfer into the coated plate. The plate was read using a MultiskanTM FC Microplate 228 
  
Photometer plate reader and results calculated using a 5 point logistic regression curve using 229 
Thermo Scientific SkanItTM for MultiskanTM FC software (version 2.5.1) (Thermo Fisher 230 
Scientific Inc, Waltham, Massachusetts, USA). Samples were spread across nine assay runs, 231 
balanced as much as possible for treatment, sample type (colostrum or serum), for gilts and 232 
sows and between farrowing batches. Duplicate samples with a coefficient of variation (CV) 233 
above 10% were repeated and those that failed to reach a CV% of less than 10% were left as 234 
missing values. The assay range was 1.37 – 1000 ng/ml.  235 
The lower and upper detectable limits of the samples analysed were 4.76 and 77.37 236 
ng/ml respectively. The average intra-assay CV was 6.66% (7.79, 6.91, 4.51, 6.69, 9.35, 6.17, 237 
6.58, 9.07 and 2.82 for assay runs 1 to 9 respectively) and the inter-assay CV was 8.69%.  238 
Data analysis 239 
Unless stated at the start of each results section, data were available for all individuals. 240 
Due to an error in the treatment allocation for gilts, there were 11 gilts and 16 sows in the 241 
ketoprofen treated group and 13 gilts and 16 sows in the saline control group. An additional 242 
factor in this study was that 13 individuals; 5 gilts (4 treated and 1 control treatment) and 8 243 
sows (4 treated and 4 control treatments) required additional treatment in the days after 244 
farrowing for PPDS. Therefore, data were analysed by treatment (treated vs. control), parity 245 
group at the level of gilt vs. sow and whether additional treatment was needed (yes vs. no). All 246 
data were analysed and descriptive statistics calculated using R version 3.3.1 (R core team, 247 
2013). All figures were plotted using the ggplot2 function, and any correlations were conducted 248 
using the spearman.test function. Results were considered statistically significant at P < 0.05. 249 
  
Feed intake 250 
 Feed consumed was analysed with linear mixed models, using the lmer function, with 251 
dam identity and batch in the random model. Initially, total feed consumed was analysed with 252 
treatment (treated or control), parity group (gilt or sow) and additional treatment (yes or no) 253 
and their interactions as fixed factors. Then each of the factor interactions with day was tested 254 
(0, 1, 2, 3, 4, 5, 6, and 7), including: day × treatment, day × gilt/sow and day × additional 255 
treatment. Post hoc analyses were conducted using the lsmeans function. 256 
Immunoglobulin-G (IgG) 257 
 Colostrum IgG concentrations (mg/ml) were analysed using linear mixed models with 258 
the lmer function, with batch in the random model. Treatment (treated or control), parity group 259 
(gilt or sow) and additional treatment (yes or no), and their interactions, and the number of 260 
piglets born alive were added as fixed factors. Piglet serum IgG was also analysed using the 261 
lmer function, with dam identity and batch in the random model, also with treatment (treated 262 
or control), parity group (gilt or sow) and additional treatment (yes or no) and their interactions, 263 
and piglets born alive as fixed factors. A Spearman’s rank correlation coefficient was 264 
calculated between piglet weight (kg) and IgG concentration (mg/ml), resulting in no 265 
significant correlation (rho = 0.039, P = 0.64), therefore piglet weight was not included in the 266 
model. 267 
Production data 268 
 The frequency of piglets born alive, still born, and number weaned, as well as live-born 269 
pre-weaning deaths were analysed at the litter level with a generalized linear mixed model, 270 
using the glmer function, using a Poisson distribution and log link function. Sow weights, bat-271 
fat thickness, and piglet weights and crown rump distances were analysed using linear mixed 272 
  
models with the lmer function. The number of piglets born alive was included as a random 273 
variable in the piglet mortality model. Gilt/sow identity and batch were included in the random 274 
model for the piglet measures, and batch for the sow measures. Treatment, additional treatment, 275 
gilt or sow and the interactions as fixed factors in all models. No piglets were fostered before 276 
the 6 hour post-injection sampling, therefore fostered piglets were analysed with their birth 277 
dam for the 6 hour post-injection measures, and with their foster dam for the other piglet 278 
measures. Sow weight and back-fat thickness was then analysed with moving in or post-279 
weaning as a fixed factor, also with batch and ID in the random model. Body condition scores 280 
were analysed with ordinal logistic regression models using the polr function, with treatment, 281 
additional treatment, gilt or sow and the interactions, and batch as fixed factors, and with 282 
moving-in or post-weaning, and batch as fixed factors. 283 
Piglets that were born alive were allocated as dead (yes) or alive (no) by weaning. A 284 
stepwise binomial logistic regression was conducted using the glm and AIC.step functions, to 285 
analyse associations between variables, and whether piglets died before weaning (yes or no). 286 
Variables included: treatment (treated or control), additional treatment (yes or no), gilt or sow, 287 
batch, litter size at birth, piglet gender, piglet post 6 hour weight, and whether the piglet was 288 
fostered (yes or no), as well as sow back-fat, body condition score, farrowing duration 289 
(previously obtained from video footage), and lie lateral duration from behavioural 290 
observations. Variables were chosen, based on available data, and including known risk factors 291 
for piglet mortality (e.g. Baxter and Edwards, 2015).  292 
Behaviour 293 
Postures (stand, sit, kneel, lie lateral, lie ventral), suckle grunting and the duration when 294 
there were more than 50 % of piglets active at the udder, were converted to percentages of the 295 
three hour observation duration. The frequency of posture changes during the three hour 296 
  
observation period was also calculated. Individual bouts of suckle grunting were exported from 297 
The Observer for each gilt or sow, to calculate the frequency of bouts, the mean duration of 298 
each bout, and the mean inter-bout intervals. These behavioural variables were analysed using 299 
linear mixed models with the lmer function, including treatment (treated or control), parity 300 
group (gilt or sow) and additional treatment (yes or no) and their interactions as fixed factors, 301 
with batch in the random model. 302 
Results 303 
Feed intake 304 
 Total feed consumed did not differ by treatment × gilt/sow (t = -0.49, P = 0.62), 305 
treatment × additional treatment (t = 1.39, P = 0.17), or gilt/sow × additional treatment (t = 306 
1.19, P = 0.23), by treatment (t = 0.33, P = 0.74), or between gilts and sows (t = 1.37, P = 0.17) 307 
(Fig.1). However, total feed consumed differed by day × additional treatment (t = -3.65, P = 308 
0.0003), day × gilt/sow (t = 3.20, P = 0.002), and overall by additional treatment (t = -2.92, P 309 
= 0.004). Post hoc analysis revealed that sows consumed more feed compared with gilts on 310 
days 6 and 7 post-farrowing (Fig.1 b) and that although individuals requiring additional 311 
treatment consumed less feed throughout, the difference was not significant until day 2 post 312 
farrowing (Fig.1 c). 313 
Immunoglobulin-G (IgG) 314 
Colostrum IgG concentrations were available for 52 of the 56 gilts and sows. No 315 
significant interactions (treatment × gilt/sow: t = 0.40, P = 0.69; treatment × additional 316 
treatment: t = 0.85, P = 0.40; gilt/sow × additional treatment: t = -0.32, P = 0.75) were found, 317 
or differences for treatment (t = -0.81, P = 0.42), between gilts and sows (t = 0.73, P = 0.47), 318 
or with additional treatment (t = -0.14, P = 0.89) (Fig.2, A-C). 319 
  
Of the 168 piglets that were blood sampled, serum IgG concentrations were available 320 
for 147 piglets. There were no differences by treatment × gilt/sow (t = -0.75, P = 0.46), 321 
treatment × additional treatment (t = 1.03, P = 0.31), or gilt/sow × additional treatment (t = -322 
0.78, P = 0.44). Piglets from sows had greater IgG concentrations than those from gilts (t = 323 
2.10, P = 0.04), but piglet serum IgG, did not differ by treatment (t = -0.15, P = 0.88), or 324 
additional treatment (t = -0.22, P = 0.82) (Fig.2, D-F).   325 
Production data 326 
Table 1 presents production information, including litter, gilt/sow- and piglet-based 327 
measures, by treatment, for gilts and sows, and by additional treatment. Table 2 presents the 328 
total frequencies and causes of death, and frequencies of piglets fostered on and off treated and 329 
control gilts and sows, to illustrate the total numbers of piglet deaths by treatment for gilts and 330 
sows, and the imbalance in piglet fostering between treatments. Figure 3 is a dot plot showing 331 
the number of live-born deaths for individual treated and control gilts and sows, which shows 332 
the individual variation in piglet pre-weaning deaths. There were no significant treatment × 333 
gilt/sow, treatment × additional treatment, or gilt/sow × additional treatment interactions for 334 
any of the results presented in Table 1 (P > 0.05). As shown, none of the results presented 335 
differed by treatment, or additional treatment (P > 0.05). However, pre-farrow and post-wean 336 
weight differed between gilts and sows, as did the piglet weight and crown-rump measurements 337 
for piglets from gilts and sows (see Table 1). In addition, gilt or sow weight (t = -12.25, P < 338 
0.001), back-fat (t = -10.66, P < 0.001), and body-condition (t = -5.12, P < 0.001) were greater 339 
overall pre-farrowing, compared with post-weaning.  340 
Of the 705 piglets born alive, any row with missing values for any of the variables was 341 
excluded, leaving 659 rows of data for analysis. The best logistic regression model included 342 
the variables piglets born alive, additional treatment, piglet gender, sow back-fat, and piglet 6 343 
  
hour post-injection weight, which were significant predictors of death before weaning. For 344 
every increase in piglet born alive in the litter, the log odds of dying before weaning increased 345 
(log-odds = 0.11, P = 0.03). Requiring additional treatment (log-odds = 0.87, P = 0.006), as 346 
well as being male (log-odds = 0.97, P = 0.0005) increased the log odds of dying before 347 
weaning. For every mm increase in gilt or sow back-fat, the log-odds of piglet death increased 348 
(log-odds = 0.16, P < 0.0001). Every kg increase in piglet 6 hour post-injection bodyweight, 349 
decreased the log-odds of dying before weaning, (log-odds = -4.18, P < 0.0001). 350 
Behaviour 351 
Behaviour was observed for 53 of the 56 individuals and results are shown in Table 2. 352 
There were no significant interactions for treatment × gilt/sow, treatment × additional 353 
treatment, or gilt/sow × additional treatment, for any of the behaviours shown in Table 3 (P > 354 
0.05).  For nursing behaviour, ketoprofen treated dams suckle grunted less (t = -2.02, P = 0.05) 355 
than the controls, but there were no other differences between treatment groups, gilts and sows 356 
and those requiring additional treatment or not (P > 0.05). For the postures observed, sitting 357 
and kneeling behaviour differed between gilts and sows (t = 2.08, P = 0.04 and t = 2.49, P = 358 
0.02 respectively), with greater values for sows compared with gilts. Lying lateral also differed 359 
(t = -2.38, P = 0.02) with greater values for gilts than sows. There were no differences in 360 
drinking behaviour between treatment groups, gilts and sows or those requiring additional 361 
treatment or not (P > 0.05). 362 
Discussion  363 
This study investigated effects of the provision of the NSAID ketoprofen to gilts and 364 
sows following farrowing. Few effects of the treatment were seen, with production parameters 365 
being more affected by whether individuals were treated for disease, or between gilts and sows.  366 
  
Feed intake 367 
 In contrast to a previous study (Viitasaari et al., 2013), there was no difference in feed 368 
consumption by gilts or sows given ketoprofen compared with controls. The previous study 369 
administered ketoprofen for three consecutive days following farrowing, which could have had 370 
a greater effect on sows, and overall feed refusal rather than consumption was measured 371 
(Viitasaari et al., 2013). In another study where the NSAID meloxicam was administered for 372 
three days post-farrowing, feed intake was not affected by drug treatment, but a difference 373 
between primiparous and multiparous sows was found, as multiparous sows had consumed a 374 
greater number of meals within an hour of feeding on days one, two and three post-farrowing 375 
(Mainau et al., 2012). In the current study, sows consumed more feed than gilts on days six and 376 
seven post-farrowing, as sows increased their feed intake at a greater rate than gilts. The feed 377 
that was not consumed was only measured at the next feeding time in this study, whereas the 378 
previous study scored feed as being completely consumed or not, one hour after it was given 379 
(Mainau et al., 2012). From day two after farrowing, and overall, there was a difference in the 380 
amount of feed consumed by individuals that required additional treatment compared to those 381 
that did not. This is not surprising as reduced feed intake is a good indicator of illness. In future 382 
studies, it would be interesting to measure the latency to feed and the time taken to fully 383 
consume the meal, as this could be an early indicator of subclinical PPDS and prompt treatment 384 
could produce a better outcome for the sow and litter. 385 
Immune transfer 386 
 Piglets obtain passive immunity through the ingestion of immunoglobulin from sow 387 
colostrum (Rooke and Bland, 2002), and those with low concentrations of immunoglobulin are 388 
less likely to survive (Cabrera et al., 2012). Therefore, this is an important measure in 389 
identifying the benefits of administering post-farrowing NSAIDs. No differences in colostrum 390 
  
or piglet serum IgG concentrations were detected in this study with drug treatment or whether 391 
additional treatment was required. A previous study found greater colostrum concentrations of 392 
piglets on day one and two post-farrowing from sows given oral meloxicam at farrowing 393 
(Mainau et al., 2016). As piglets were numerically heavier at six hours post-injection in this 394 
study, which could indicate greater colostrum intake, a difference may have been found if 395 
piglets were sampled at later time points. 396 
Some studies have shown a link between colostrum intake and piglet birth weight 397 
(Devillers et al., 2007; Fraser and Rushen, 1992; Nguyen et al., 2013; Quesnel, 2011), although 398 
the link between colostrum consumed and piglet plasma IgG concentration plateau over a 399 
certain value, i.e. the link is stronger at lower concentrations (Devillers et al., 2011). No 400 
association between piglet weight and IgG at the point of sampling was found in this study, 401 
which was similar to a previous study (Cabrera et al., 2012), however, this could be explained 402 
by excessively small and/or weak piglets not being selected for blood sampling in the current 403 
and previous study (Cabrera et al., 2012). In addition, Fraser and Rushen, (1992) suggest that 404 
the failure to find a link between birth weight and IgG could be because of differences in blood 405 
volume (affecting the concentration) between large and small piglets.  406 
Sow colostrum had a numerically greater IgG concentration than gilt colostrum, and 407 
piglet serum IgG was greater for piglets from sows compared with gilts. No link between piglet 408 
plasma IgG concentration and parity was detected at birth in one study (Quesnel, 2011), and 409 
another study showed a similar result, although it was not mentioned whether primiparous sows 410 
were included (Nguyen et al., 2013). Other studies measuring sow colostrum have found 411 
differences by parity, including lower concentrations measured 24 hours after birth in lower 412 
parity sows (Quesnel, 2011) and lower colostrum IgG concentrations in primiparous compared 413 
with multiparous sows 48-72 hours after birth (Cabrera et al., 2012). 414 
  
Production data  415 
 There were no overall significant differences in pre-weaning piglet deaths, weight or 416 
size by treatment, or between those requiring additional treatment or not. However, it is worth 417 
discussing that numerically fewer piglets died in the ketoprofen compared with the saline-418 
treated group, especially for gilts. High individual variation in piglet mortality was seen in this 419 
study, which possibly resulted in this difference not reaching significance. As piglet weight six 420 
hours after the injection was also numerically greater in ketoprofen-treated gilts and sows, it is 421 
also possible that piglet birth weight was greater for treated gilts and sows, resulting in the 422 
mortality difference. It is also possible that ketoprofen treatment increased piglet weight at six 423 
hours through increased colostrum intake, however, based on previous studies measuring early 424 
piglet weight gain, this may not have accounted for all of this weight difference (e.g. de Passillé 425 
and Rushen, 1989; Fraser and Rushen, 1992; Quesnel, 2011). This cannot be confirmed, since 426 
piglets were not weighed before the injection was given, and in a previous study, where 16 427 
sows were randomly allocated to be given butorphanol tartrate or a saline placebo post-428 
farrowing, Haussmann et al., (1999) found a significant difference in birth weight of the piglets, 429 
with those from control sows being significantly heavier. So this may be an accidental outcome 430 
in this study and an important consideration for the piglet mortality difference between 431 
treatment groups.  432 
A reduction in piglet mortality with the use of ketoprofen post-farrowing has been 433 
demonstrated previously in a study of 15 commercial farms (Homedes et al., 2014) and on a 434 
farm with a high incidence of PPDS (Sabaté et al., 2012), but another study reported no 435 
difference in mortality with the use of ketoprofen (Viitasaari et al., 2013). The individuals 436 
responsible for the care of the animals in the current study were blind to the treatments, and 437 
cross-fostering was performed to even litter size, resulting in more piglets being fostered off 438 
  
the ketoprofen-treated gilts and more piglets being fostered onto the control gilts. This meant, 439 
despite a difference in mortality, no difference in the numbers of piglets weaned was detected 440 
between treatment groups for gilts, which is a result found in previously, where fostering was 441 
only conducted within treatment groups (Homedes et al., 2014; Sabaté et al., 2012). If 442 
ketoprofen does have an influence on piglet mortality, given the individual variation in the 443 
number of deaths, early identification to enable targeted use of drugs to those that could benefit 444 
the most would be the best use of drugs. No difference in mortality between treatment groups 445 
was detected the post-farrowing administration of the NSAID meloxicam (Mainau et al., 2012; 446 
Tenbergen et al., 2014) or with the opioid butorphanol tartrate (Haussmann et al., 1999). 447 
However, average daily weight gain of low birth weight piglets (<1180g) was increased 448 
(Mainau et al., 2012), growth rate of medium sized litters (11 to 13 piglets) tended to be greater 449 
(Tenbergen et al., 2014), and average daily gain and weaning weight was greater (Mainau et 450 
al., 2016) for multiparous sows treated with meloxicam compared with a placebo.  451 
Piglet mortality in this study was most influenced by previously demonstrated risk 452 
factors, including piglet weight, sow back-fat, piglet gender, sow post-farrowing illness and 453 
the number of piglets born alive (for a review see Baxter and Edwards, 2015). It is widely 454 
agreed that birth weight is the most important factor in neonatal piglet survival and lower 455 
average piglet weight at six hours post-injection in this study was most strongly associated with 456 
pre-weaning death. Larger litter sizes come at the expense of reduced piglet viability, as well 457 
as increased competition for colostrum and milk (Baxter and Edwards, 2015). Interestingly, 458 
greater sow back-fat was associated with an increase in the odds of a piglet dying before 459 
weaning. A previous study using a high number of sows found a quadratic effect of sow back-460 
fat at farrowing on the number of piglets weaned, with low and high back-fat being associated 461 
with fewer piglets weaned (Kim et al., 2015). Male-biased pre-weaning mortality has been 462 
found elsewhere, where piglets born were male-biased, and males were heavier at birth (Baxter 463 
  
et al., 2012). This demonstrates a life-history strategy in domestic pig populations, with greater 464 
pre-natal maternal investment and an over-supply of more vulnerable males, in expectation of 465 
greater mortality (Baxter et al., 2012). Litter from sows developing PPDS suffer greater 466 
mortality (Klopfenstein et al., 2006), and treatment with NSAIDs in addition to antibiotics, can 467 
aid in the treatment of infectious causes of PPDS (Sabaté et al., 2012; Tummaruk and Sang-468 
Gassanee, 2013).   469 
Behaviour 470 
Posture was observed during nursing behaviour observations, with no differences by 471 
treatment. Previous studies investigating the administration of ketoprofen (Viitasaari et al., 472 
2014) and meloxicam (Mainau et al., 2012) for three consecutive days post-farrowing showed 473 
differences in the level of activity between individuals given the NSAID or a saline placebo 474 
only on the third day post farrowing. This included a decrease in the time spent lying by 475 
meloxicam treated gilts and sows (Mainau et al., 2012) and an increased activity in younger 476 
(parity 2 -3) sows treated with ketoprofen, compared with their placebo treated counterparts, 477 
although older sows did not differ (Viitasaari et al., 2014). Greater activity suggests an 478 
improvement in the speed of recovery following parturition with the use of NSAIDs. By 479 
contrast, another study, using the opioid analgesic butorphanol tartrate post-farrowing showed 480 
a reduced number of posture changes 48 hours post farrowing (Haussmann et al., 1999).  481 
Sows showed more sitting and kneeling behaviour compared with gilts, which could be 482 
related to the difference in size, weight and fitness between these two groups and the ease of 483 
changing body position. The gilts in this study spent more time lying lateral, in contrast to a 484 
previous study that showed younger sows to be more active (Viitasaari et al., 2014). This could 485 
be due to genetic improvements, as the gilts in this study were acquired directly from a breeding 486 
company, whereas the sows were home bred from an older genetic line of the same breed. 487 
  
Modern breeding programs have focused on maternal traits to improve productivity, which 488 
could be reflected in greater lateral lying, allowing piglets access to the udder. Although there 489 
were no significant differences in posture between individuals that required additional 490 
treatment for PPDS, numerical differences for postures and the frequency of posture changes 491 
indicate PPDS individuals appear less active and, as with a reduction in feed intake, could be 492 
used as an early indication of PPDS to provide prompt treatment.      493 
For the nursing behaviours observed, there was greater suckle grunting in control, 494 
compared with ketoprofen-treated dams. These data could indicate that ketoprofen dams had 495 
settled into a pattern of milk let-down sooner, providing support for the fact that the weight 496 
difference between ketoprofen and control-treatment dams could be due to greater colostrum 497 
intake. No previous studies have recorded nursing behaviour in relation to the use of post-498 
farrowing NSAIDs. 499 
Conclusion 500 
This study did not demonstrate production benefits to the immediate post-farrowing 501 
administration of ketoprofen. However, in this study, as with others, high individual sow 502 
variation in piglet mortality was seen, with some performing well and the majority of piglet 503 
mortality often coming from a low number of sows (Baxter et al., 2015; Hales et al., 2013). 504 
Investigating whether pain is a component of decreased performance in these sows, could 505 
enable the targeted use of drugs. Additionally, identifying sows that could benefit from pain 506 
relief using measures of farrowing ease (e.g. Mainau et al., 2010), feed intake, activity and 507 
other behaviour measures, could assist with targeted drug treatment. 508 
Acknowledgements 509 
The authors are grateful to BBSRC and Zoetis for funding this collaborative award in science 510 
and engineering (CASE) PhD studentship (BB/J500549/1: ‘Addressing pain at parturition in 511 
  
pigs’). The authors would also like to thank Marianne Farish, Colin Arthur, Jo Donbavand, 512 
Naomi Scott, Jessica Martin and the pig unit staff for technical assistance during on-farm data 513 
collection, and Sarah Hall and Jennifer Coe for assistance with IgG assays. Useful discussion 514 
throughout the project from Alistair Lawrence and Eddie Clutton, was gratefully received.   515 
  
References 516 
Baxter, E., Rutherford, K., D’Eath, R., Arnott, G., Turner, S., Sandøe, P., Moustsen, V., 517 
Thorup, F., Edwards, S., Lawrence, A., 2013. The welfare implications of large litter 518 
size in the domestic pig II: management factors. Anim. Welf. 22, 219–238. 519 
doi:10.7120/09627286.22.2.219 520 
Baxter, E.M., Adeleye, O.O., Jack, M.C., Farish, M., Ison, S.H., Edwards, S.A., 2015. 521 
Achieving optimum performance in a loose-housed farrowing system for sows: the 522 
effects of space and temperature. Appl. Anim. Behav. Sci. 523 
Baxter, E.M., Edwards, S.A., 2015. Piglet mortality: causes and prevention, in: Farmer, C. 524 
(Ed.), The Gestating and Lactating Sow. Wageningen Academic Publishers, pp. 253–525 
278. 526 
Baxter, E.M., Jarvis, S., Palarea-Albaladejo, J., Edwards, S.A., 2012. The weaker sex? the 527 
propensity for male-biased piglet mortality. PLoS One 7. 528 
doi:10.1371/journal.pone.0030318 529 
Cabrera, R.A., Lin, X., Campbell, J.M., Moeser, A.J., Odle, J., 2012. Influence of birth order, 530 
birth weight, colostrum and serum immunoglobulin G on neonatal piglet survival. J. 531 
Anim. Sci. Biotechnol. 3, 42. doi:10.1186/2049-1891-3-42 532 
Castren, H., Algers, B., Jensen, P., Saloniemi, H., 1989. Suckling behaviour and milk 533 
consumption in newborn piglets as a response to sow grunting. Appl. Anim. Behav. Sci. 534 
24, 227–238. doi:10.1016/0168-1591(89)90069-5 535 
de Passillé, A.M.B., Rushen, J., 1989. Using Early Suckling Behavior and Weight Gain To 536 
Identify Piglets At Risk. Can. J. Anim. Sci. 69, 535–544. doi:10.4141/cjas89-066 537 
Devillers, N., Farmer, C., Le Dividich, J., Prunier, A., 2007. Variability of colostrum yield 538 
and colostrum intake in pigs. Animal 1, 1033. doi:10.1017/S175173110700016X 539 
Devillers, N., Le Dividich, J., Prunier, A., 2011. Influence of colostrum intake on piglet 540 
survival and immunity. Animal 5, 1605–1612. doi:10.1017/S175173111100067X 541 
Fosse, T.K., Toutain, P.L., Spadavecchia, C., Haga, H. a., Horsberg, T.E., Ranheim, B., 2011. 542 
Ketoprofen in piglets: Enantioselective pharmacokinetics, pharmacodynamics and 543 
PK/PD modelling. J. Vet. Pharmacol. Ther. 34, 338–349. doi:10.1111/j.1365-544 
2885.2010.01236.x 545 
Fraser, D., Rushen, J., 1992. Colostrum intake by newborn piglets. Can. J. Anim. Sci. 72, 1–546 
13. doi:10.4141/cjas92-001 547 
Friendship, R.M., O’Sullivan, T.L., 2015. Sow health, in: Farmer, C. (Ed.), The Gestating 548 
and Lactating Sow. Wageningen Academic Publishers, pp. 409–422. 549 
Hales, J., Moustsen, V. a, Nielsen, M.B.F., Hansen, C.F., 2013. Higher preweaning mortality 550 
in free farrowing pens compared with farrowing crates in three commercial pig farms. 551 
Animal 8, 113–120. doi:10.1017/S1751731113001869 552 
Haussmann, M.F., Lay, D.C., Buchanan, H.S., Hopper, J.G., 1999. Butorphanol tartrate acts 553 
to decrease sow activity, which could lead to reduced pig crushing. J. Anim. Sci. 2054–554 
2059. 555 
  
Hirsch, A.C., Philipp, H., Kleemann, R., 2003. Investigation on the efficacy of meloxicam in 556 
sows with mastitis-metritis-agalactia syndrome. J. Vet. Pharmacol. Ther. 26, 355–60. 557 
Homedes, J., Salichs, M., Sabaté, D., Sust, M., Fabre, R., 2014. Effect of ketoprofen on pre-558 
weaning piglet mortality on commercial farms. Vet. J. 201, 435–7. 559 
doi:10.1016/j.tvjl.2014.05.038 560 
Kim, J.S., Yang, X.J., Pangeni, D., Baidoo, S.K., 2015. Relationship between backfat 561 
thickness of sows during late gestation and reproductive efficiency at different parities. 562 
Acta Agric. Scand. Sect. A — Anim. Sci. 65, 1–8. doi:10.1080/09064702.2015.1045932 563 
Klopfenstein, C., Farmer, C., Martineau, G.-P., 2006. Diseases of the mammary glands, in: 564 
Straw, B.E., Zimmermans, J.J., D’Allaire, S., Taylor, D.J. (Eds.), Diseases of Swine. 565 
Blackwell Publishing, pp. 57–85. 566 
Mainau, E., Dalmau,  a, Ruiz-de-la-Torre, J.L., Manteca, X., 2010. A behavioural scale to 567 
measure ease of farrowing in sows. Theriogenology 74, 1279–87. 568 
doi:10.1016/j.theriogenology.2010.05.034 569 
Mainau, E., Ruiz-de-la-Torre, J.L., Dalmau, A., Salleras, J.M., Manteca, X., 2012. Effects of 570 
meloxicam (Metacam®) on post-farrowing sow behaviour and piglet performance. 571 
Animal 6, 494–501. doi:10.1017/S1751731111001790 572 
Mainau, E., Temple, D., Manteca, X., 2016. Experimental study on the effect of oral 573 
meloxicam administration in sows on pre-weaning mortality and growth and 574 
immunoglobulin G transfer to piglets. Prev. Vet. Med. 126, 48–53. 575 
doi:10.1016/j.prevetmed.2016.01.032 576 
Nguyen, K., Cassar, G., Friendship, R.M., Dewey, C., Farzan,  a, Kirkwood, R.N., Hodgins, 577 
D., 2013. An investigation of the impacts of induced parturition, birth weight, birth 578 
order, litter size, and sow parity on piglet serum concentrations of immunoglobulin G. J. 579 
swine Heal. Prod. 21, 139–43. 580 
Peltoniemi, O.A.T., Oliviero, C., 2015. Housing, management and environment during 581 
farrowing and early lactation, in: Farmer, C. (Ed.), The Gestating and Lactating Sow. 582 
Wageningen Academic Publishers, pp. 231–252. doi:10.3920/978-90-8686-803-2 583 
Quesnel, H., 2011. Colostrum production by sows: variability of colostrum yield and 584 
immunoglobulin G concentrations. Animal 5, 1546–1553. 585 
doi:10.1017/S175173111100070X 586 
Raekallio, M.R., Mustonen, K.M., Heinonen, M.L., Peltoniemi, O.A.T., Säkkinen, M.S., 587 
Peltoniemi, S.M., Honkavaara, J.M., Vainio, O.M., 2008. Evaluation of bioequivalence 588 
after oral, intramuscular, and intravenous administration of racemic ketoprofen in pigs. 589 
Am. J. Vet. Res. 69, 108–113. 590 
Rooke, J.A., Bland, I.M., 2002. The acquisition of passive immunity in the new-born piglet. 591 
Livest. Prod. Sci. 78, 13–23. doi:10.1016/S0301-6226(02)00182-3 592 
Sabaté, D., Salichs, M., Bosch, J., Ramó, P., Homedes, J., 2012. Efficacy of ketoprofen in the 593 
reduction of pre-weaning piglet mortality associated with sub-clinical forms of post-594 
partum dysgalactia syndrome in sows. Pig J. 67, 19–23. 595 
Tenbergen, R., Friendship, R., Cassar, G., Amezcua, M.R., Haley, D., 2014. Investigation of 596 
  
the use of meloxicam post farrowing for improving sow performance and reducing pain. 597 
J. Swine Heal. Prod. 22, 10–15. 598 
Theil, P.K., 2015. Transition feeding of sows, in: Farmer, C. (Ed.), The Gestating and 599 
Lactating Sow. Wageningen Academic Publishers, pp. 147–172. 600 
Tummaruk, P., Sang-Gassanee, K., 2013. Effect of farrowing duration, parity number and the 601 
type of anti-inflammatory drug on postparturient disorders in sows: A clinical study. 602 
Trop. Anim. Health Prod. 45, 1071–1077. doi:10.1007/s11250-012-0315-x 603 
Viitasaari, E., Hänninen, L., Heinonen, M., Raekallio, M., Orro, T., Peltoniemi, O., Valros, 604 
A., 2013. Effects of post-partum administration of ketoprofen on sow health and piglet 605 
growth. Vet. J. 198, 153–157. doi:10.1016/j.tvjl.2013.06.013 606 
Viitasaari, E., Raekallio, M., Heinonen, M., Valros, A., Peltoniemi, O., Hänninen, L., 2014. 607 
The effect of ketoprofen on post-partum behaviour in sows. Appl. Anim. Behav. Sci. 608 
158, 16–22. doi:10.1016/j.applanim.2014.06.005 609 
 610 
  611 
  
Fig.1. Mean ± SEM of the total feed consumed (kg) per day by a) treatment (treated or 612 
control); b) gilts and sows and; c) additional treatment (yes or no). Bars with a * indicate a 613 
significant difference (P < 0.05). 614 
615 
  
Fig.2. Mean ± SEM for colostrum immunoglobulin-G concentrations (mg/ml) for A) gilts and sows × treatment; B) additional treatment (yes or 616 
no) × drug treatment and; C) additional treatment (yes or no) × gilts and sows. Mean ± SEM for piglet serum immunoglobulin-G concentrations 617 
(mg/ml) for D) gilts and sows × treatment; E) additional treatment (yes or no) × drug treatment and; F) additional treatment (yes or no) × gilts 618 
and sows. Labels on the bars indicate the number of samples represente619 
620 
  
Fig.3. Dot plot of individual gilt or sow live-born piglet deaths by treatment. 621 
 622 
  
Table 1. Production information presented by treatment, gilts and sows, and additional treatment, including litter-based measures, gilts/sow based 623 
measures taken before moving in and at weaning, and piglet-based measures. Body condition was scored from 1 to 5 (1 = very thin, 5 = very fat) 624 
Gilt/sow data with different letters, represents an overall difference pre-farrowing, compared with post-weaning (P < 0.001). *One sow weaning 625 
weight is missing.  626 
Production data 
Treatment  Gilt or sow  Additional treatment  
Treated Control P Gilt Sow P Yes No P 
Litter data          
Born alive, frequency 12.6±0.7 13.0±0.7 0.92 12.3±0.8 13.2±0.6 0.65 13.5±0.9 12.6±0.5 0.65 
Still born, frequency 0.4±0.2 0.5±0.2 0.66 0.2±0.1 0.7±0.2 0.16 0.3±0.2 0.5±0.1 0.99 
Number weaned, frequency 10.7±0.4 10.9±0.3 0.91 10.8±0.4 10.9±0.3 0.62 10.5±0.4 10.9±0.3 0.72 
Live-born deaths, frequency 2.4±0.3 3.0±0.4 0.37 2.5±0.3 2.9±0.4 0.83 3.4±0.6 2.5±0.3 0.23 
Gilt/sow data          
a Pre farrow weight, kg 260.2±7.7 261.5±7.7 0.87 223.4±5.8 289.0±3.5 0.00003 266.5±10.9 259.2±6.3 0.89 
b Post wean weight, kg 228.5±7.9 231.7±7.9 0.96 199.2±5.96 254.2±5.1* 0.01 228.2±12.5 230.8±5.9 0.52 
a Pre farrow back-fat, mm 19.0±0.8 18.8±0.9 0.44 17.4±0.9 20.0±0.8 0.33 19.1±1.4 18.8±0.7 0.48 
b Post wean back-fat, mm 14.0±0.8 14.2±0.7 0.93 13.3±0.9 14.7±0.6 0.85 13.5±0.9 14.3±0.6 0.79 
a Pre farrow body condition score 3.1±0.1 3.2±0.1 0.69 3.3±0.1 3.1±0.1 0.34 3.2±0.1 3.2±0.04 0.54 
b Post wean body condition score 2.6±0.1 2.7±0.1 0.18 2.7±0.1 2.7±0.1 0.35 2.7±0.1 2.7±0.1 0.87 
Piglet data          
Piglet 6 hour weight, kg 1.5±0.02 1.4±0.02 0.19 1.3±0.02 1.51±0.02 0.002 1.5±0.03 1.4±0.02 0.87 
Piglet 6 hour crown-rump, cm 27.1±0.1 26.4±0.1 0.34 25.8±0.1 27.37±0.12 0.002 26.9±0.2 26.7±0.1 0.74 
Piglet day 3 weight, kg 1.8±0.02 1.7±0.02 0.25 1.7±0.02 1.86±0.02 0.009 1.8±0.03 1.8±0.02 0.57 
Piglet wean weight, kg 8.00±0.1 7.6±0.1 0.24 7.2±0.1 8.16±0.09 0.008 7.6±0.2 7.8±0.1 0.75 
Piglet wean crown-rump, cm 50.3±0.3 49.5±0.2 0.62 48.7±0.3 50.72±0.25 0.06 49.2±0.4 50.1±0.2 0.74 
627 
  
Table 2. Frequencies of pre-weaning deaths, including totals and separated by suspected cause 628 
of death, and the frequencies of piglets that were fostered on and off the litter for the 11 treated 629 
and 13 control gilts and 16 treated and 16 control sows. 630 
 GILT SOW 
Totals 
Treated (n = 11) Control (n = 13) Treated (n = 16) Control (n = 16) 
Crushed 4 12 7 10 33 
Low viability 2 8 8 8 26 
Starve 1 1 6 7 15 
Savage 0 1 4 1 6 
Greasy pig 2 2 2 10 16 
Other 0 3 1 2 6 
Total deaths 9 27 28 38 102 
Fostered on 4 13 5 7 29 
Fostered off 14 5 11 12 42 
631 
  
Table 3. Behaviour results (mean ± SEM) by treatment, gilts or sows and additional treatment, for three hour observations between 15 and 18 632 
hours after the last piglet was born. Results are displayed as a percentage of time in the three hour observation (% of time), frequency of events in 633 
the observation, duration in seconds or minutes. Columns with a different letter indicate a difference (P < 0.05). 634 
Behaviour 
Treatment Gilts vs. Sow Additional treatment 
Treated Control Gilt Sow Yes No 
Sow behaviour       
Stand, % of time 
Sit, % of time 
Kneel, % of time 
Lie lateral, % of time 
Lie ventral, % of time 
Posture changes, frequency 
  8.4±1.5 
   1.1±0.3 
    0.1±0.04 
79.7±3.3 
10.7±2.9 
12.8±1.8 
 9.2±1.9 
  2.2±0.5 
   0.1±0.03 
77.2±3.6 
11.3±2.9 
  13.3±2.1 
 7.6±1.6 
  1.1±0.2a  
0.1±0.01a 
83.3±2.9a 
 8.0±1.9 
11.1±1.7 
 9.8±1.8 
  2.2±0.5b 
    0.2±0.04b 
 74.4±3.7b 
13.5±3.3 
14.7±2.1 
  6.1±1.6 
  1.8±1.1 
  0.1±0.04 
86.1±3.5 
  5.9±2.4 
  9.6±2.7 
 9.4±1.4 
 1.6±0.3 
   0.1±0.03 
76.6±2.8 
12.2±2.4 
13.9±1.6 
Drinking, seconds 121.2±25.0 122.1±26.6 124.5±31.0 119.3±21.4 142.0±38.4 116.9±20.6 
Nursing behaviour       
> 50 % of piglets active at udder, % of time 
Suckle grunt duration, % of time 
Suckle grunt bouts, frequency 
Mean suckle grunt bout duration, seconds 
Inter bout interval, minutes 
16.9±1.3 
 11.9±0.9a 
  5.2±0.4 
 254.9±8.9 
34.0±2.3 
18.7±1.2 
 14.5±1.0b 
  5.9±0.4 
276.7±10.5 
30.6±1.9 
17.8±1.2 
13.8±1.1 
 5.4±0.4 
280.8±11.6 
32.3±2.3 
17.8±1.3 
12.8±0.9 
  5.7±0.5 
253.7±8.0 
32.2±2.0 
16.9±1.8 
11.2±0.9 
  5.0±0.5 
245.6±15.7 
33.3±2.2 
18.1±1.0 
13.7±0.8 
  5.7±0.4 
 270.7±7.8 
   32.0±1.8 
 635 
